These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11815446)

  • 1. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations.
    Kuo CC; Campbell LA; Rosenfeld ME
    Circulation; 2002 Jan; 105(4):E34. PubMed ID: 11815446
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.
    Ieven MM; Hoymans VY
    J Clin Microbiol; 2005 Jan; 43(1):19-24. PubMed ID: 15634945
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of infection in the development of immune inflammation and pathogenesis of atherosclerosis].
    Nagornev VA; Mal'tseva SV
    Arkh Patol; 2000; 62(6):55-9. PubMed ID: 11198124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae and coronary artery disease: legitimized linkages?
    Higgins JP; Higgins JA; Higgins PM; Ahuja S; Higgins DL
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):367-84. PubMed ID: 15030265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Egr-1, a major link between infection and atherosclerosis?
    Rupp J; Maass M
    Circ Res; 2003 May; 92(9):e78. PubMed ID: 12750307
    [No Abstract]   [Full Text] [Related]  

  • 11. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae.
    Blessing E; Campbell LA; Rosenfeld ME; Chesebro B; Kuo CC
    J Antimicrob Chemother; 2005 Jun; 55(6):1037-40. PubMed ID: 15845780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat-inactivated C. pneumoniae organisms are not atherogenic.
    Sharma J; Niu Y; Ge J; Pierce GN; Zhong G
    Mol Cell Biochem; 2004 May; 260(1-2):147-52. PubMed ID: 15228096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection?
    Shor A
    Circulation; 2002 Oct; 106(18):e135-6; disscussion e135-6. PubMed ID: 12403680
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    Clin Infect Dis; 2005 Apr; 40(8):1131-2. PubMed ID: 15791512
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of infection in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):671-6. PubMed ID: 15810509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.
    Liu C; Waters DD
    Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
    Sawayama Y; Okada K; Maeda S; Ohnishi H; Furusyo N; Hayashi J
    Fukuoka Igaku Zasshi; 2006 Aug; 97(8):245-55. PubMed ID: 17087362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of asthma in wheezing infants with Chlamydia pneumoniae infection.
    Zaitsu M
    J Asthma; 2007 Sep; 44(7):565-8. PubMed ID: 17885860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chlamydia pneumoniae and its relation with human atherosclerosis].
    Gutiérrez J; Linares-Palomino J; Rodríguez M; Maroto MC
    Rev Invest Clin; 2000; 52(5):482-6. PubMed ID: 11195174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.